Furthermore, the use of TH5487, a pharmacological inhibitor of OGG1, in the middle stage of lung fibrosis, has been shown to alleviate BLM-induced lung fibrosis in murine models [62]. The gene discussed is OGG1; the disease is pulmonary fibrosis.